Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
Civeo reports Q3 EPS 0c, consensus 25c » 07:11
10/28/21
10/28
07:11
10/28/21
07:11
CVEO

Civeo

$22.11 /

-0.6 (-2.64%)

Reports Q3 revenue…

Reports Q3 revenue $155.1M, consensus $154.99M. "In Q3, Civeo made significant progress towards our financial objectives. We replaced and refinanced our entire credit agreement, announced the board authorization of a share repurchase program and generated significant free cash flow in a tough operating environment. During the quarter we reduced our total leverage ratio below 2.0x and reduced our aggregate total debt below $200M" stated CEO Bradley Dodson, CFO Carolyn Stone added "We were pleased to announce our new bank agreement, which provides the Company with four years of tenor. This longer tenor affords us the flexibility to evaluate other capital allocation priorities, such as our recently announced share repurchase program and potential growth opportunities."

ShowHide Related Items >><<
CVEO Civeo
$22.11 /

-0.6 (-2.64%)

CVEO Civeo
$22.11 /

-0.6 (-2.64%)

Hot Stocks
Beneficial owner of Civeo Lance Torgerson sells $370K in shares » 17:41
09/22/21
09/22
17:41
09/22/21
17:41
CVEO

Civeo

$22.76 /

+0.86 (+3.93%)

Beneficial owner of…

Beneficial owner of Civeo, Lance Torgerson, disclosed in a filing that he had sold 16,790 shares of company stock at $22.04 per share, between September 20 and September 21, for a total transaction value of $369,973.

ShowHide Related Items >><<
CVEO Civeo
$22.76 /

+0.86 (+3.93%)

CVEO Civeo
$22.76 /

+0.86 (+3.93%)

Over a quarter ago
Hot Stocks
Civeo board authorizes repurchase of up to 5% of total common shares outstanding » 16:31
08/30/21
08/30
16:31
08/30/21
16:31
CVEO

Civeo

$21.45 /

-0.52 (-2.37%)

Civeo Corporation…

Civeo Corporation announced that its Board of Directors has authorized the Company to repurchase up to 5% of its total common shares outstanding, or approximately 715,000 common shares, through the facilities of the New York Stock Exchange over the next twelve months. Civeo intends to fund repurchases through cash on hand and cash generated from operations. "Today's announcement reflects our confidence in Civeo's business and the future of this company. We believe this share repurchase program provides an opportunity to acquire shares at an attractive valuation, while continuing to allocate a majority of our free cash flow generation towards debt reduction," said Bradley J. Dodson, Civeo's President & Chief Executive Officer.

ShowHide Related Items >><<
CVEO Civeo
$21.45 /

-0.52 (-2.37%)

Earnings
Civeo backs FY21 revenue view of $555M-$580M, consensus $554.96M » 06:36
07/30/21
07/30
06:36
07/30/21
06:36
CVEO

Civeo

$22.00 /

+0.3 (+1.38%)

Backs FY21 adjusted…

Backs FY21 adjusted EBITDA view of $90M-$100M. Lowers FY21 CapEx view to $15M-$20M.

ShowHide Related Items >><<
CVEO Civeo
$22.00 /

+0.3 (+1.38%)

CVEO Civeo
$22.00 /

+0.3 (+1.38%)

Earnings
Civeo reports Q2 EPS (3c), consensus (17c) » 06:35
07/30/21
07/30
06:35
07/30/21
06:35
CVEO

Civeo

$22.00 /

+0.3 (+1.38%)

Reports Q2 revenue…

Reports Q2 revenue $154.2M, consensus $132.79M. "In Q2, we once again stuck to our objectives of operating safely, generating free cash flow and reducing our debt balance. Q2 marks our eighth consecutive quarter of debt and leverage ratio reduction," stated CEO Bradley Dodson. "In Canada, we are encouraged and thankful for the rapid decline of COVID-19 cases after the strong third wave occurred in April, and as a result, customer activity in the Canadian oil sands and pipeline work continued to strengthen. In Australia, Civeo and its customers continue to deal with labor supply issues and subdued activity due to COVID-19 travel restrictions and the lingering China/Australia trade dispute, but we continue to view these issues as transitory. Australia has been more successful in finding demand for its met coal exports, and Australian met coal is now trading above $200/ton, an increase of almost 100% since Q1."

ShowHide Related Items >><<
CVEO Civeo
$22.00 /

+0.3 (+1.38%)

CVEO Civeo
$22.00 /

+0.3 (+1.38%)

Earnings
Civeo reports Q1 EPS (70c), one estimate (56c) » 06:32
04/30/21
04/30
06:32
04/30/21
06:32
CVEO

Civeo

$17.10 /

+0.06 (+0.35%)

Reports Q1 revenue…

Reports Q1 revenue $125.4M, one estimate $125.3M. "Despite recent macroeconomic headwinds and winter seasonality, we continued to generate solid free cash flow and reduced our total debt. I continue to be encouraged by our team's ability to operate safely and effectively in this tough environment, while also progressing our strategic and financial initiatives. For the Q1 our Canadian business saw a sequential improvement in occupancy despite the British Columbia health order impacting our occupancy at our Sitka location. The Australian business had a softer quarter than expected due to a slow start to the year in the Bowen Basin and continued difficulty in sourcing labor in both our village operations and our integrated services business. The U.S. business had sequentially improved results as U.S. drilling and completion activity continued to recover and increased occupancy at our Louisiana location related to the hurricane recovery efforts in Lake Charles," stated Bradley J. Dodson, Civeo's President and CEO.

ShowHide Related Items >><<
CVEO Civeo
$17.10 /

+0.06 (+0.35%)

CVEO Civeo
$17.10 /

+0.06 (+0.35%)

Conference/Events
Lytham Partners to hold a virtual conference » 04:55
04/01/21
04/01
04:55
04/01/21
04:55
LIQT

LiqTech

$8.20 /

+0.15 (+1.86%)

, OPSSF

Opsens

$0.00 /

+ (+0.00%)

, CVEO

Civeo

$15.55 /

+0.38 (+2.50%)

, NBAC

Newborn Acquisition Corp.

$15.44 /

+ (+0.00%)

, JETMF

Global Crossing Airlines

$0.00 /

+ (+0.00%)

, VNRX

VolitionRx

$3.76 /

+0.41 (+12.24%)

, JOB

GEE Group

$1.26 /

-0.12 (-8.70%)

, LPCN

Lipocine

$1.51 /

+0.07 (+4.86%)

, SSKN

Strata Skin Sciences

$1.68 /

+0.02 (+1.20%)

, CAE

CAE

$28.53 /

+0.21 (+0.74%)

, CNTY

Century Casinos

$10.30 /

+0.13 (+1.28%)

, CHFS

CHF Solutions

$5.90 /

-0.105 (-1.75%)

, IDEX

Ideanomics

$2.93 /

+0.08 (+2.81%)

, KWR

Quaker Houghton

$243.77 /

+3.05 (+1.27%)

, PCYO

Pure Cycle

$13.43 /

+0.46 (+3.55%)

Spring 2021 Virtual…

Spring 2021 Virtual Conference will be held on March 30-April 1.

ShowHide Related Items >><<
VNRX VolitionRx
$3.76 /

+0.41 (+12.24%)

SSKN Strata Skin Sciences
$1.68 /

+0.02 (+1.20%)

NBAC Newborn Acquisition Corp.
$15.44 /

+ (+0.00%)

LPCN Lipocine
$1.51 /

+0.07 (+4.86%)

KWR Quaker Houghton
$243.77 /

+3.05 (+1.27%)

IDEX Ideanomics
$2.93 /

+0.08 (+2.81%)

CVEO Civeo
$15.55 /

+0.38 (+2.50%)

CNTY Century Casinos
$10.30 /

+0.13 (+1.28%)

CHFS CHF Solutions
$5.90 /

-0.105 (-1.75%)

CAE CAE
$28.53 /

+0.21 (+0.74%)

LIQT LiqTech
$8.20 /

+0.15 (+1.86%)

10/15/20 Stephens
LiqTech resumed with an Equal Weight at Stephens
10/02/20 B. Riley
LiqTech price target raised to $11 from $8 at B. Riley Securities
OPSSF Opsens
$0.00 /

+ (+0.00%)

02/01/21 Raymond James
Opsens initiated with an Outperform at Raymond James
01/14/21 RBC Capital
Opsens price target raised to C$2 from C$1.50 at RBC Capital
11/23/20 RBC Capital
Opsens price target raised to C$1.50 from C$1.25 at RBC Capital
07/16/20 RBC Capital
Opsens price target lowered to C$1.25 from C$1.50 at RBC Capital
CVEO Civeo
$15.55 /

+0.38 (+2.50%)

NBAC Newborn Acquisition Corp.
$15.44 /

+ (+0.00%)

JETMF Global Crossing Airlines
$0.00 /

+ (+0.00%)

VNRX VolitionRx
$3.76 /

+0.41 (+12.24%)

03/09/21 Cantor Fitzgerald
VolitionRx initiated with an Overweight at Cantor Fitzgerald
11/13/20 Oppenheimer
VolitionRx vet test could be bridge with human tests delayed, says Oppenheimer
05/06/20 Aegis
VolitionRx initiated with a Buy at Aegis
JOB GEE Group
$1.26 /

-0.12 (-8.70%)

02/16/21 Alliance Global Partners
Alliance Global Partners ups GEE Group target to $2.75 on revenue recovery
08/17/20 Alliance Global Partners
GEE Group price target lowered to $1.75 from $2.50 at Alliance Global Partners
07/02/20 Alliance Global Partners
Alliance Global upgrades GEE on elimination of bankruptcy risk
07/02/20 Alliance Global Partners
GEE Group upgraded to Buy from Neutral at Alliance Global Partners
LPCN Lipocine
$1.51 /

+0.07 (+4.86%)

12/10/20 Ladenburg
Lipocine upgraded to Buy after tentative Tlando approval at Ladenburg
12/10/20 Ladenburg
Lipocine upgraded to Buy from Neutral at Ladenburg
05/27/20 H.C. Wainwright
Lipocine price target raised to $3 from $2 at H.C. Wainwright
SSKN Strata Skin Sciences
$1.68 /

+0.02 (+1.20%)

11/03/20
Fly Intel: Top five analyst upgrades
11/03/20 H.C. Wainwright
Strata Skin Sciences upgraded to Buy from Neutral at H.C. Wainwright
CAE CAE
$28.53 /

+0.21 (+0.74%)

03/16/21 Desjardins
CAE resumed with a Buy from Hold at Desjardins
03/11/21 Scotiabank
CAE price target lowered to C$44 from C$45 at Scotiabank
03/03/21 CIBC
CAE price target raised to C$42 from C$36 at CIBC
03/03/21 Desjardins
CAE price target raised to C$40 from C$36 at Desjardins
CNTY Century Casinos
$10.30 /

+0.13 (+1.28%)

03/12/21 Stifel
Century Casinos price target raised to $12 from $9 at Stifel
12/09/20 Stifel
Century Casinos resumed with a Buy at Stifel
CHFS CHF Solutions
$5.90 /

-0.105 (-1.75%)

10/21/20 Maxim
CHF Solutions price target lowered to $20 from $45 at Maxim
06/05/20 Maxim
CHF Solutions initiated with a Buy at Maxim
IDEX Ideanomics
$2.93 /

+0.08 (+2.81%)

KWR Quaker Houghton
$243.77 /

+3.05 (+1.27%)

03/29/21 Deutsche Bank
Quaker Houghton price target lowered to $300 from $320 at Deutsche Bank
12/21/20 Sidoti
Quaker Houghton reinstated with a Neutral at Sidoti
12/11/20 Deutsche Bank
Quaker Houghton initiated with a Buy at Deutsche Bank
05/13/20 Janney Montgomery Scott
Quaker Houghton downgraded to Neutral from Buy at Janney Montgomery Scott
PCYO Pure Cycle
$13.43 /

+0.46 (+3.55%)

VNRX VolitionRx
$3.76 /

+0.41 (+12.24%)

SSKN Strata Skin Sciences
$1.68 /

+0.02 (+1.20%)

LPCN Lipocine
$1.51 /

+0.07 (+4.86%)

LIQT LiqTech
$8.20 /

+0.15 (+1.86%)

KWR Quaker Houghton
$243.77 /

+3.05 (+1.27%)

IDEX Ideanomics
$2.93 /

+0.08 (+2.81%)

CVEO Civeo
$15.55 /

+0.38 (+2.50%)

CNTY Century Casinos
$10.30 /

+0.13 (+1.28%)

CHFS CHF Solutions
$5.90 /

-0.105 (-1.75%)

CAE CAE
$28.53 /

+0.21 (+0.74%)

  • 17
    Mar
  • 10
    Mar
  • 10
    Feb
  • 26
    Jan
  • 20
    May
CAE CAE
$28.53 /

+0.21 (+0.74%)

IDEX Ideanomics
$2.93 /

+0.08 (+2.81%)

CAE CAE
$28.53 /

+0.21 (+0.74%)

LPCN Lipocine
$1.51 /

+0.07 (+4.86%)

IDEX Ideanomics
$2.93 /

+0.08 (+2.81%)

Conference/Events
Lytham Partners to hold a virtual conference » 04:55
03/31/21
03/31
04:55
03/31/21
04:55
LIQT

LiqTech

$8.05 /

+0.12 (+1.51%)

, OPSSF

Opsens

$0.00 /

+ (+0.00%)

, CVEO

Civeo

$15.20 /

-0.825 (-5.15%)

, NBAC

Newborn Acquisition Corp.

$15.44 /

+ (+0.00%)

, JETMF

Global Crossing Airlines

$0.00 /

+ (+0.00%)

, VNRX

VolitionRx

$3.35 /

-0.09 (-2.62%)

, JOB

GEE Group

$1.38 /

-0.0899 (-6.12%)

, LPCN

Lipocine

$1.44 /

+0.06 (+4.35%)

, SSKN

Strata Skin Sciences

$1.66 /

+0.02 (+1.22%)

, CAE

CAE

$28.32 /

-0.15 (-0.53%)

, CNTY

Century Casinos

$10.15 /

+0.01 (+0.10%)

, CHFS

CHF Solutions

$6.00 /

-0.01 (-0.17%)

, IDEX

Ideanomics

$2.85 /

+0.05 (+1.79%)

, KWR

Quaker Houghton

$240.53 /

+5.51 (+2.34%)

, PCYO

Pure Cycle

$13.03 /

-0.045 (-0.34%)

Spring 2021 Virtual…

Spring 2021 Virtual Conference will be held on March 30-April 1.

ShowHide Related Items >><<
VNRX VolitionRx
$3.35 /

-0.09 (-2.62%)

SSKN Strata Skin Sciences
$1.66 /

+0.02 (+1.22%)

NBAC Newborn Acquisition Corp.
$15.44 /

+ (+0.00%)

LPCN Lipocine
$1.44 /

+0.06 (+4.35%)

KWR Quaker Houghton
$240.53 /

+5.51 (+2.34%)

IDEX Ideanomics
$2.85 /

+0.05 (+1.79%)

CVEO Civeo
$15.20 /

-0.825 (-5.15%)

CNTY Century Casinos
$10.15 /

+0.01 (+0.10%)

CHFS CHF Solutions
$6.00 /

-0.01 (-0.17%)

CAE CAE
$28.32 /

-0.15 (-0.53%)

LIQT LiqTech
$8.05 /

+0.12 (+1.51%)

10/15/20 Stephens
LiqTech resumed with an Equal Weight at Stephens
10/02/20 B. Riley
LiqTech price target raised to $11 from $8 at B. Riley Securities
OPSSF Opsens
$0.00 /

+ (+0.00%)

02/01/21 Raymond James
Opsens initiated with an Outperform at Raymond James
01/14/21 RBC Capital
Opsens price target raised to C$2 from C$1.50 at RBC Capital
11/23/20 RBC Capital
Opsens price target raised to C$1.50 from C$1.25 at RBC Capital
07/16/20 RBC Capital
Opsens price target lowered to C$1.25 from C$1.50 at RBC Capital
CVEO Civeo
$15.20 /

-0.825 (-5.15%)

NBAC Newborn Acquisition Corp.
$15.44 /

+ (+0.00%)

JETMF Global Crossing Airlines
$0.00 /

+ (+0.00%)

VNRX VolitionRx
$3.35 /

-0.09 (-2.62%)

03/09/21 Cantor Fitzgerald
VolitionRx initiated with an Overweight at Cantor Fitzgerald
11/13/20 Oppenheimer
VolitionRx vet test could be bridge with human tests delayed, says Oppenheimer
05/06/20 Aegis
VolitionRx initiated with a Buy at Aegis
JOB GEE Group
$1.38 /

-0.0899 (-6.12%)

02/16/21 Alliance Global Partners
Alliance Global Partners ups GEE Group target to $2.75 on revenue recovery
08/17/20 Alliance Global Partners
GEE Group price target lowered to $1.75 from $2.50 at Alliance Global Partners
07/02/20 Alliance Global Partners
Alliance Global upgrades GEE on elimination of bankruptcy risk
07/02/20 Alliance Global Partners
GEE Group upgraded to Buy from Neutral at Alliance Global Partners
LPCN Lipocine
$1.44 /

+0.06 (+4.35%)

12/10/20 Ladenburg
Lipocine upgraded to Buy after tentative Tlando approval at Ladenburg
12/10/20 Ladenburg
Lipocine upgraded to Buy from Neutral at Ladenburg
05/27/20 H.C. Wainwright
Lipocine price target raised to $3 from $2 at H.C. Wainwright
SSKN Strata Skin Sciences
$1.66 /

+0.02 (+1.22%)

11/03/20
Fly Intel: Top five analyst upgrades
11/03/20 H.C. Wainwright
Strata Skin Sciences upgraded to Buy from Neutral at H.C. Wainwright
CAE CAE
$28.32 /

-0.15 (-0.53%)

03/16/21 Desjardins
CAE resumed with a Buy from Hold at Desjardins
03/11/21 Scotiabank
CAE price target lowered to C$44 from C$45 at Scotiabank
03/03/21 CIBC
CAE price target raised to C$42 from C$36 at CIBC
03/03/21 Desjardins
CAE price target raised to C$40 from C$36 at Desjardins
CNTY Century Casinos
$10.15 /

+0.01 (+0.10%)

03/12/21 Stifel
Century Casinos price target raised to $12 from $9 at Stifel
12/09/20 Stifel
Century Casinos resumed with a Buy at Stifel
CHFS CHF Solutions
$6.00 /

-0.01 (-0.17%)

10/21/20 Maxim
CHF Solutions price target lowered to $20 from $45 at Maxim
06/05/20 Maxim
CHF Solutions initiated with a Buy at Maxim
IDEX Ideanomics
$2.85 /

+0.05 (+1.79%)

KWR Quaker Houghton
$240.53 /

+5.51 (+2.34%)

03/29/21 Deutsche Bank
Quaker Houghton price target lowered to $300 from $320 at Deutsche Bank
12/21/20 Sidoti
Quaker Houghton reinstated with a Neutral at Sidoti
12/11/20 Deutsche Bank
Quaker Houghton initiated with a Buy at Deutsche Bank
05/13/20 Janney Montgomery Scott
Quaker Houghton downgraded to Neutral from Buy at Janney Montgomery Scott
PCYO Pure Cycle
$13.03 /

-0.045 (-0.34%)

VNRX VolitionRx
$3.35 /

-0.09 (-2.62%)

SSKN Strata Skin Sciences
$1.66 /

+0.02 (+1.22%)

LPCN Lipocine
$1.44 /

+0.06 (+4.35%)

LIQT LiqTech
$8.05 /

+0.12 (+1.51%)

KWR Quaker Houghton
$240.53 /

+5.51 (+2.34%)

IDEX Ideanomics
$2.85 /

+0.05 (+1.79%)

CVEO Civeo
$15.20 /

-0.825 (-5.15%)

CNTY Century Casinos
$10.15 /

+0.01 (+0.10%)

CHFS CHF Solutions
$6.00 /

-0.01 (-0.17%)

CAE CAE
$28.32 /

-0.15 (-0.53%)

  • 17
    Mar
  • 10
    Mar
  • 10
    Feb
  • 26
    Jan
  • 20
    May
CAE CAE
$28.32 /

-0.15 (-0.53%)

IDEX Ideanomics
$2.85 /

+0.05 (+1.79%)

CAE CAE
$28.32 /

-0.15 (-0.53%)

LPCN Lipocine
$1.44 /

+0.06 (+4.35%)

IDEX Ideanomics
$2.85 /

+0.05 (+1.79%)

Conference/Events
Lytham Partners to hold a virtual conference » 09:36
03/30/21
03/30
09:36
03/30/21
09:36
LIQT

LiqTech

$8.00 /

+ (+0.00%)

, OPSSF

Opsens

$0.00 /

+ (+0.00%)

, CVEO

Civeo

$15.85 /

+0.02 (+0.13%)

, NBAC

Newborn Acquisition Corp.

$15.44 /

+ (+0.00%)

, JETMF

Global Crossing Airlines

$0.00 /

+ (+0.00%)

, VNRX

VolitionRx

$3.44 /

-0.06 (-1.71%)

, JOB

GEE Group

$1.47 /

-0.07 (-4.55%)

, LPCN

Lipocine

$1.38 /

-0.09 (-6.12%)

, SSKN

Strata Skin Sciences

$1.64 /

-0.06 (-3.53%)

, CAE

CAE

$28.50 /

+0.42 (+1.50%)

, CNTY

Century Casinos

$10.15 /

-0.26 (-2.50%)

, CHFS

CHF Solutions

$6.01 /

+0.15 (+2.56%)

, IDEX

Ideanomics

$2.80 /

+0.02 (+0.72%)

, KWR

Quaker Houghton

$234.21 /

-0.94 (-0.40%)

, PCYO

Pure Cycle

$13.09 /

-0.05 (-0.38%)

Spring 2021 Virtual…

Spring 2021 Virtual Conference will be held on March 30-April 1.

ShowHide Related Items >><<
VNRX VolitionRx
$3.44 /

-0.06 (-1.71%)

SSKN Strata Skin Sciences
$1.64 /

-0.06 (-3.53%)

NBAC Newborn Acquisition Corp.
$15.44 /

+ (+0.00%)

LPCN Lipocine
$1.38 /

-0.09 (-6.12%)

KWR Quaker Houghton
$234.21 /

-0.94 (-0.40%)

IDEX Ideanomics
$2.80 /

+0.02 (+0.72%)

CVEO Civeo
$15.85 /

+0.02 (+0.13%)

CNTY Century Casinos
$10.15 /

-0.26 (-2.50%)

CHFS CHF Solutions
$6.01 /

+0.15 (+2.56%)

CAE CAE
$28.50 /

+0.42 (+1.50%)

LIQT LiqTech
$8.00 /

+ (+0.00%)

10/15/20 Stephens
LiqTech resumed with an Equal Weight at Stephens
10/02/20 B. Riley
LiqTech price target raised to $11 from $8 at B. Riley Securities
OPSSF Opsens
$0.00 /

+ (+0.00%)

02/01/21 Raymond James
Opsens initiated with an Outperform at Raymond James
01/14/21 RBC Capital
Opsens price target raised to C$2 from C$1.50 at RBC Capital
11/23/20 RBC Capital
Opsens price target raised to C$1.50 from C$1.25 at RBC Capital
07/16/20 RBC Capital
Opsens price target lowered to C$1.25 from C$1.50 at RBC Capital
CVEO Civeo
$15.85 /

+0.02 (+0.13%)

NBAC Newborn Acquisition Corp.
$15.44 /

+ (+0.00%)

JETMF Global Crossing Airlines
$0.00 /

+ (+0.00%)

VNRX VolitionRx
$3.44 /

-0.06 (-1.71%)

03/09/21 Cantor Fitzgerald
VolitionRx initiated with an Overweight at Cantor Fitzgerald
11/13/20 Oppenheimer
VolitionRx vet test could be bridge with human tests delayed, says Oppenheimer
05/06/20 Aegis
VolitionRx initiated with a Buy at Aegis
JOB GEE Group
$1.47 /

-0.07 (-4.55%)

02/16/21 Alliance Global Partners
Alliance Global Partners ups GEE Group target to $2.75 on revenue recovery
08/17/20 Alliance Global Partners
GEE Group price target lowered to $1.75 from $2.50 at Alliance Global Partners
07/02/20 Alliance Global Partners
Alliance Global upgrades GEE on elimination of bankruptcy risk
07/02/20 Alliance Global Partners
GEE Group upgraded to Buy from Neutral at Alliance Global Partners
LPCN Lipocine
$1.38 /

-0.09 (-6.12%)

12/10/20 Ladenburg
Lipocine upgraded to Buy after tentative Tlando approval at Ladenburg
12/10/20 Ladenburg
Lipocine upgraded to Buy from Neutral at Ladenburg
05/27/20 H.C. Wainwright
Lipocine price target raised to $3 from $2 at H.C. Wainwright
SSKN Strata Skin Sciences
$1.64 /

-0.06 (-3.53%)

11/03/20
Fly Intel: Top five analyst upgrades
11/03/20 H.C. Wainwright
Strata Skin Sciences upgraded to Buy from Neutral at H.C. Wainwright
CAE CAE
$28.50 /

+0.42 (+1.50%)

03/16/21 Desjardins
CAE resumed with a Buy from Hold at Desjardins
03/11/21 Scotiabank
CAE price target lowered to C$44 from C$45 at Scotiabank
03/03/21 CIBC
CAE price target raised to C$42 from C$36 at CIBC
03/03/21 Desjardins
CAE price target raised to C$40 from C$36 at Desjardins
CNTY Century Casinos
$10.15 /

-0.26 (-2.50%)

03/12/21 Stifel
Century Casinos price target raised to $12 from $9 at Stifel
12/09/20 Stifel
Century Casinos resumed with a Buy at Stifel
CHFS CHF Solutions
$6.01 /

+0.15 (+2.56%)

10/21/20 Maxim
CHF Solutions price target lowered to $20 from $45 at Maxim
06/05/20 Maxim
CHF Solutions initiated with a Buy at Maxim
IDEX Ideanomics
$2.80 /

+0.02 (+0.72%)

KWR Quaker Houghton
$234.21 /

-0.94 (-0.40%)

03/29/21 Deutsche Bank
Quaker Houghton price target lowered to $300 from $320 at Deutsche Bank
12/21/20 Sidoti
Quaker Houghton reinstated with a Neutral at Sidoti
12/11/20 Deutsche Bank
Quaker Houghton initiated with a Buy at Deutsche Bank
05/13/20 Janney Montgomery Scott
Quaker Houghton downgraded to Neutral from Buy at Janney Montgomery Scott
PCYO Pure Cycle
$13.09 /

-0.05 (-0.38%)

VNRX VolitionRx
$3.44 /

-0.06 (-1.71%)

SSKN Strata Skin Sciences
$1.64 /

-0.06 (-3.53%)

LPCN Lipocine
$1.38 /

-0.09 (-6.12%)

LIQT LiqTech
$8.00 /

+ (+0.00%)

KWR Quaker Houghton
$234.21 /

-0.94 (-0.40%)

IDEX Ideanomics
$2.80 /

+0.02 (+0.72%)

CVEO Civeo
$15.85 /

+0.02 (+0.13%)

CNTY Century Casinos
$10.15 /

-0.26 (-2.50%)

CHFS CHF Solutions
$6.01 /

+0.15 (+2.56%)

CAE CAE
$28.50 /

+0.42 (+1.50%)

  • 17
    Mar
  • 10
    Mar
  • 10
    Feb
  • 26
    Jan
  • 20
    May
CAE CAE
$28.50 /

+0.42 (+1.50%)

IDEX Ideanomics
$2.80 /

+0.02 (+0.72%)

CAE CAE
$28.50 /

+0.42 (+1.50%)

LPCN Lipocine
$1.38 /

-0.09 (-6.12%)

IDEX Ideanomics
$2.80 /

+0.02 (+0.72%)

Hot Stocks
Civeo falls -9.3% » 12:00
03/01/21
03/01
12:00
03/01/21
12:00
CVEO

Civeo

$16.97 /

-1.94 (-10.26%)

Civeo is down -9.3%, or…

Civeo is down -9.3%, or -$1.75 to $17.04.

ShowHide Related Items >><<
CVEO Civeo
$16.97 /

-1.94 (-10.26%)

CVEO Civeo
$16.97 /

-1.94 (-10.26%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.